Drug intelligence / Profile preview

siCAMK1D

Development stage
Preclinical
Modality
Chemically Modified siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Conjugated siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
Administration
Intravenous
01

Overview

siCAMK1D is a small interfering RNA (siRNA) designed to specifically target and silence the expression of Calcium/calmodulin-dependent protein kinase ID (CAMK1D). CAMK1D is a kinase involved in various signaling pathways, and its overexpression has been linked to the maintenance of prostate cancer stem-like cells (PCaSCs) and the promotion of an immunosuppressive tumor microenvironment in enzalutamide-resistant prostate cancer. By utilizing RNA interference (RNAi), siCAMK1D reduces CAMK1D protein levels, which in turn suppresses the phosphorylation of CREB and downregulates key stemness genes such as CD44 and CD133. This molecular intervention helps to reverse enzalutamide resistance, decrease regulatory T cell infiltration, and enhance CD8+ T cell-mediated anti-tumor immunity. It is often studied in conjunction with targeted delivery systems, such as CD44-targeted nanoparticles (e.g., EC@HNA), to improve its therapeutic index and restore tumor-immune surveillance.

Other names
small interfering RNA targeting CAMK1DCAMK1D siRNACAMK-1D siRNACAMK 1D siRNA
02

Targets

CAMK1D (Calcium/calmodulin-dependent protein kinase 1D)

Beyond the preview

Go deeper on siCAMK1D.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on siCAMK1D.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call